Anne Yeakey

Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial

C. Griffin, Honghong Zhou, B. Girard, 2024, The Lancet Infectious Diseases.